Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia

Abstract Background Maternal agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AAs) have been implicated in the pathophysiology of preeclampsia, but their presence in their offsprings and their possible neonatal effects have not been specifically explored. This prospective stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Laure Ponthier, Chahrazed El Hamel, Perrine Coste Mazeau, Sophie Martinez, Sarah Wehbe, Rachel Froget, Catherine Yardin, Vincent Guigonis
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-024-07102-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559097424478208
author Laure Ponthier
Chahrazed El Hamel
Perrine Coste Mazeau
Sophie Martinez
Sarah Wehbe
Rachel Froget
Catherine Yardin
Vincent Guigonis
author_facet Laure Ponthier
Chahrazed El Hamel
Perrine Coste Mazeau
Sophie Martinez
Sarah Wehbe
Rachel Froget
Catherine Yardin
Vincent Guigonis
author_sort Laure Ponthier
collection DOAJ
description Abstract Background Maternal agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AAs) have been implicated in the pathophysiology of preeclampsia, but their presence in their offsprings and their possible neonatal effects have not been specifically explored. This prospective study aimed to evaluate the presence of AT1-AAs and their potential clinical effects in neonates of AT1-AAs positive mothers. Methods Women with preeclampsia and their neonates were included. Blood samples were collected in order to search for AT1-AAs. Results AT1-AA determination was positive in 35 out of 64 of the studied women (54.7%). Thirty one newborns from the group of AT1-AA positive women were included and 22 (71%) were AT1-AA positive. The mothers’ and children’s AT1-AAs titers were significantly correlated. The 33 newborns from the group of AT1-AA negative women were all negative for AT1-AAs. Regarding the clinical data of newborns (birth weight, percentile of weight, gestational age, Apgar score at five minutes, mechanical or noninvasive ventilation), no significant difference was observed between the children with or without detected AT1-AAs. Conclusion Even though AT1-AAs are detected in newborns of positive mothers during the first days of life, no specific clinical signs seem to be associated with the presence of these antibodies.
format Article
id doaj-art-cf7f0674947b4daa8b3a30aec2cd928c
institution Kabale University
issn 1471-2393
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj-art-cf7f0674947b4daa8b3a30aec2cd928c2025-01-05T12:49:29ZengBMCBMC Pregnancy and Childbirth1471-23932025-01-0125111010.1186/s12884-024-07102-wAngiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsiaLaure Ponthier0Chahrazed El Hamel1Perrine Coste Mazeau2Sophie Martinez3Sarah Wehbe4Rachel Froget5Catherine Yardin6Vincent Guigonis7Collection Biologique de L’Hôpital de La Mère Et de L’Enfant CB-HME (Mother and Child Biobank), University Hospital CenterCollection Biologique de L’Hôpital de La Mère Et de L’Enfant CB-HME (Mother and Child Biobank), University Hospital CenterDepartment of Obstetric Gynecology, University Hospital CenterDepartment of Obstetric Gynecology, University Hospital CenterDepartment of Obstetric Gynecology, University Hospital CenterDepartment of Pediatrics, University Hospital CenterCollection Biologique de L’Hôpital de La Mère Et de L’Enfant CB-HME (Mother and Child Biobank), University Hospital CenterCollection Biologique de L’Hôpital de La Mère Et de L’Enfant CB-HME (Mother and Child Biobank), University Hospital CenterAbstract Background Maternal agonistic autoantibodies against the angiotensin II type 1 receptor (AT1-AAs) have been implicated in the pathophysiology of preeclampsia, but their presence in their offsprings and their possible neonatal effects have not been specifically explored. This prospective study aimed to evaluate the presence of AT1-AAs and their potential clinical effects in neonates of AT1-AAs positive mothers. Methods Women with preeclampsia and their neonates were included. Blood samples were collected in order to search for AT1-AAs. Results AT1-AA determination was positive in 35 out of 64 of the studied women (54.7%). Thirty one newborns from the group of AT1-AA positive women were included and 22 (71%) were AT1-AA positive. The mothers’ and children’s AT1-AAs titers were significantly correlated. The 33 newborns from the group of AT1-AA negative women were all negative for AT1-AAs. Regarding the clinical data of newborns (birth weight, percentile of weight, gestational age, Apgar score at five minutes, mechanical or noninvasive ventilation), no significant difference was observed between the children with or without detected AT1-AAs. Conclusion Even though AT1-AAs are detected in newborns of positive mothers during the first days of life, no specific clinical signs seem to be associated with the presence of these antibodies.https://doi.org/10.1186/s12884-024-07102-wPreeclampsiaAT1-AAMothersNewbornsClinical data
spellingShingle Laure Ponthier
Chahrazed El Hamel
Perrine Coste Mazeau
Sophie Martinez
Sarah Wehbe
Rachel Froget
Catherine Yardin
Vincent Guigonis
Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
BMC Pregnancy and Childbirth
Preeclampsia
AT1-AA
Mothers
Newborns
Clinical data
title Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
title_full Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
title_fullStr Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
title_full_unstemmed Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
title_short Angiotensin II type-1 receptor autoantibodies and effects in neonates of women with preeclampsia
title_sort angiotensin ii type 1 receptor autoantibodies and effects in neonates of women with preeclampsia
topic Preeclampsia
AT1-AA
Mothers
Newborns
Clinical data
url https://doi.org/10.1186/s12884-024-07102-w
work_keys_str_mv AT laureponthier angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT chahrazedelhamel angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT perrinecostemazeau angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT sophiemartinez angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT sarahwehbe angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT rachelfroget angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT catherineyardin angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia
AT vincentguigonis angiotensiniitype1receptorautoantibodiesandeffectsinneonatesofwomenwithpreeclampsia